Cargando…

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized. We found that BTLA levels were upregulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xubin, Song, Jingjing, Chen, Buran, Qi, Yufeng, Jiang, Wenjie, Li, Huihui, Zheng, Danni, Wang, Yinghao, Zhang, Xiaohua, Liu, Haiguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953043/ https://www.ncbi.nlm.nih.gov/pubmed/33718105 http://dx.doi.org/10.3389/fonc.2020.592811

Ejemplares similares

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
por: Xie, Yalin, et al.
Publicado: (2022)

The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021)

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
por: Leeneman, Brenda, et al.
Publicado: (2020)

L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma
por: Song, Jingjing, et al.
Publicado: (2021)

Exploring the Immunotherapeutic Potential of Oleocanthal against Murine Cutaneous Leishmaniasis
por: Karampetsou, Kalliopi, et al.
Publicado: (2022)

Identification of the prognostic and immunotherapeutic potential of L antigen family member 3 in malignant pleural mesothelioma
por: Dong, Xubin, et al.
Publicado: (2020)

The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers
por: Weir, Sydney A., et al.
Publicado: (2023)

Exploration and validation of metastasis-associated genes for skin cutaneous melanoma
por: Luan, Hong, et al.
Publicado: (2022)

Expression Patterns of Necroptosis-Related Genes: Predicting Prognosis and Immunotherapeutic Effects in Cutaneous Melanoma
por: Dong, Dong, et al.
Publicado: (2022)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020)

T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAF(V600E) Mutation in Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2020)

PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma
por: Yang, Yanwen, et al.
Publicado: (2021)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018)

The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma
por: Wan, Xiaohua, et al.
Publicado: (2017)

Expression profile and prognostic values of LSM family in skin cutaneous melanoma
por: Sun, Xiaofang, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment
por: Kaimala, Suneesh, et al.
Publicado: (2018)

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanoma
por: Dong, Dong, et al.
Publicado: (2022)

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
por: Almela, Ramón M., et al.
Publicado: (2019)

Human γδ T lymphocytes for immunotherapeutic strategies against cancer
por: Kabelitz, Dieter
Publicado: (2010)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

The prognostic value of the proteasome activator subunit gene family in skin cutaneous melanoma
por: Wang, Qiaoqi, et al.
Publicado: (2019)

Prognostic and immune-related value of STK17B in skin cutaneous melanoma
por: Shi, Xueying, et al.
Publicado: (2022)

Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature
por: Ding, Xiaoxia, et al.
Publicado: (2023)

Cutaneous Spitzoid Melanoma in Childhood After Acute Lymphocytic Leukemia
por: Bassetti, Beatriz Ferreira do Prado, et al.
Publicado: (2022)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020)

Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma
por: Li, Ding, et al.
Publicado: (2020)

Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
por: Doukas, J, et al.
Publicado: (2012)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy
por: Chen, Muchao, et al.
Publicado: (2023)

Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma
por: Park, Cheol Keun, et al.
Publicado: (2017)

Cutaneous Secondary Syphilis Resembling Non-Melanoma Skin Cancer
por: Stone, Courtney E, et al.
Publicado: (2020)

Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma
por: Chen, Wuzhen, et al.
Publicado: (2020)

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
por: Huang, Runzhi, et al.
Publicado: (2022)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma
por: Ke, Guolin, et al.
Publicado: (2023)

Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines
por: Suriano, Robert, et al.
Publicado: (2013)

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
por: Wolchok, Jedd D, et al.
Publicado: (2013)

Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma
por: Middleton, Gary
Publicado: (2020)

Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
por: Biri-Kovács, Beáta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5erfa3kklsjicuvup84e4u1rtd